Your browser doesn't support javascript.
loading
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis.
Abdel-Maboud, Mohamed; Menshawy, Amr; Elgebaly, Ahmed; Bahbah, Eshak I; El Ashal, Gehad; Negida, Ahmed.
Affiliation
  • Abdel-Maboud M; Faculty of Medicine, Al-Azhar University, Cairo, Egypt. MohamedAbdel-Maboud.6.206@azhar.edu.eg.
  • Menshawy A; Al-Hussein University Hospital, Cairo, Egypt. MohamedAbdel-Maboud.6.206@azhar.edu.eg.
  • Elgebaly A; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Bahbah EI; Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • El Ashal G; Faculty of Medicine, Al-Azhar University, New Damietta, Egypt.
  • Negida A; Ministry of Health Hospitals, Cairo, Egypt.
J Thromb Thrombolysis ; 51(3): 830-832, 2021 Apr.
Article in En | MEDLINE | ID: mdl-32816197
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin / COVID-19 Drug Treatment / Anticoagulants Type of study: Systematic_reviews Limits: Humans Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2021 Document type: Article Affiliation country: Egypt Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin / COVID-19 Drug Treatment / Anticoagulants Type of study: Systematic_reviews Limits: Humans Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2021 Document type: Article Affiliation country: Egypt Country of publication: Netherlands